Showing results (401-410 of 419) with videos related to
Sort By:
Pageof 42
Crohn'S & Colitis 360|February 13, 2023
Maintenance Golimumab Treatment in Pediatric UC Patients With Moderately to Severely Active UC: PURSUIT PEDS PK Long-Term Study ResultsJeffrey S Hyams, Christopher D O'Brien, Lakshmi Padgett, et al.Journal of the American Academy of Child and Adolescent Psychiatry|March 27, 2016
Development of an Objective Autism Risk Index Using Remote Eye TrackingThomas W Frazier, Eric W Klingemier, Mary Beukemann, et al.Psychiatry Research|July 19, 2022
Epigenetic age dysregulation in individuals with bipolar disorder and schizophreniaRichie Jeremian, Alexandra Malinowski, Zanib Chaudhary, et al.Journal of Pediatric Gastroenterology and Nutrition|March 2, 2026
Effectiveness and safety of ustekinumab in pediatric Crohn's disease: Results of the REALITI studySteven J Steiner, Jeremy Adler, Shehzad A Saeed, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|May 24, 2024
Targeted rescue of synaptic plasticity improves cognitive decline in sepsis-associated encephalopathyBenedikt Grünewald, Jonathan Wickel, Nina Hahn, et al.Journal of the American Academy of Child and Adolescent Psychiatry|March 5, 2013
Beyond autism: a baby siblings research consortium study of high-risk children at three years of ageDaniel Messinger, Gregory S Young, Sally Ozonoff, et al.Psychoneuroendocrinology|June 16, 2010
No association between oxytocin or prolactin gene variants and childhood-onset mood disordersJohn S Strauss, Natalie L Freeman, Sajid A Shaikh, et al.Microbiology Spectrum|February 11, 2025
Clinical performance of Abbott ID NOW™ COVID-19 2.0 rapid molecular point-of-care test compared to three real-time RT-PCR assaysMaria D Iglesias-Ussel, Aleah Bowie, Jack G Anderson, et al.Pediatrics|July 3, 2004
Bariatric surgery for severely overweight adolescents: concerns and recommendationsThomas H Inge, Nancy F Krebs, Victor F Garcia, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 8, 2017
Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 'CREATE'P Schöffski, A Wozniak, B Kasper, et al.Pageof 42